Lithium (Orotate) 5 mg

Lithium (Orotate) 5 mg

Pure Encapsulations4.6 (83 ratings)
Format:Capsule Quantity: 180 Capsule(s) · 180 servings
Goals
$47.50 $0.26 per serving

Product analysis

78 out of 100

Lithium (Orotate) 5 mg is aimed at mood support, with its lithium form and amount clearly stated. Effects from monitored prescription lithium treatment cannot be assumed for this supplement.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality91

The lithium compound is clearly identified as orotate. The precise NAC preparation is not disclosed, limiting a comparison of the complete formula.

Ingredient Transparency81

Both ingredient amounts are stated, making the main contents identifiable. Lithium orotate is named, while the precise NAC preparation is missing.

Value For Money60

The cost per lithium serving appears reasonable. That price comparison does not establish an effective mood-support serving.

Customer Satisfaction68

Customer ratings are favorable. The small number of ratings leaves a limited satisfaction picture and does not establish mood effects.

Product Focus81

The formula has a narrow mood-support aim, but a general mood benefit at this supplement exposure is not established. Findings from monitored prescription lithium treatment cannot be transferred to it.

Format
Capsule
Container
180 Capsule(s)
Per serving
$0.26
Customer rating
4.6 · 83 ratings
Report analysis

Goals

Mood Support
Impact
Highest effect
A- Ingredient FitC- PathwaysB+ EvidenceA+ Formulation Logic
Study evidence
Lithium Supportive 197 studies

Ingredients

IngredientAmount per servingScore
Lithium (Lithium Orotate)
5 mg 92
N-Acetyl L-Cysteine
200 mg
Gluten Free Adults 18–50 Women
Report overview
A+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyC Value
It provides 5 mg of lithium per serving at a moderate cost per serving. The source is lithium orotate.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

It contains lithium orotate; the available information does not establish how its absorption compares with other forms.
Lithium Compound Optimization
It contains lithium orotate; the available information does not establish how its absorption compares with other forms.

Dose, Safety & Label Transparency100

The label states the lithium amount per serving. The serving provides 5 mg of lithium.
Elemental Disclosure Precision
The label states 5 mg of elemental lithium per serving.
Dosage Appropriateness
The serving provides 5 mg of lithium.

Value60

The cost per serving is moderate.
Cost Per Serving Efficiency
The cost per serving is moderate.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
    Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M · Bipolar disorders · 2019
    Guideline / consensusMood Support forLithium
  2. GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
    Young RC; Mulsant BH; Sajatovic M; Gildengers AG; Gyulai L; Al Jurdi RK; Beyer J; Evans J; Banerjee S; Greenberg R; Marino P; Kunik ME; Chen P; Barrett M; Schulberg HC; Bruce ML; Reynolds CF; Alexopoulos GS; GERI-BD Study Group · The American journal of psychiatry · 2017
    Randomized trial224 participantsMood Support forLithium
  3. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J; Lamictal 606 Study Group · Archives of general psychiatry · 2003
    Randomized trial175 participantsMood Support forLithium
  4. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Mishima K; Iwata N · Molecular psychiatry · 2022
    Meta-analysis9,821 participants41 studies pooledMood Support forLithium
  5. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
    Goodwin GM; Bowden CL; Calabrese JR; Grunze H; Kasper S; White R; Greene P; Leadbetter R · The Journal of clinical psychiatry · 2004
    Meta-analysis638 participants2 studies pooledMood Support forLithium